Divis Laboratories Ltd — Profit & Loss Statement

₹5947.00

-1.42%

Divis Laboratories Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022
Tax Effect Of Unusual Items	0.25 Cr	0.26 Cr	0.92 Cr	-0.40 Cr
Tax Rate For Calcs	0.25	0.26	0.23	0.20
Normalized EBITDA	3.32K Cr	2.54K Cr	2.71K Cr	4.00K Cr
Total Unusual Items	1.00 Cr	1.00 Cr	4.00 Cr	-2.05 Cr
Total Unusual Items Excluding Goodwill	1.00 Cr	1.00 Cr	4.00 Cr	-2.05 Cr
Net Income From Continuing Operation Net Minority Interest	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Reconciled Depreciation	402.00 Cr	378.00 Cr	343.00 Cr	311.51 Cr
Reconciled Cost Of Revenue	3.87K Cr	3.27K Cr	3.18K Cr	3.09K Cr
EBITDA	3.32K Cr	2.54K Cr	2.71K Cr	4.00K Cr
EBIT	2.92K Cr	2.17K Cr	2.37K Cr	3.68K Cr
Net Interest Income	292.00 Cr	297.00 Cr	203.00 Cr	66.96 Cr
Interest Expense	2.00 Cr	3.00 Cr	0.00	0.37 Cr
Interest Income	295.00 Cr	301.00 Cr	205.00 Cr	68.96 Cr
Normalized Income	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Net Income From Continuing And Discontinued Operation	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Total Expenses	6.75K Cr	5.96K Cr	5.64K Cr	5.23K Cr
Rent Expense Supplemental	15.00 Cr	12.00 Cr	12.00 Cr	10.77 Cr
Diluted Average Shares	26.55 Cr	26.55 Cr	26.55 Cr	26.55 Cr
Basic Average Shares	26.55 Cr	26.55 Cr	26.55 Cr	26.55 Cr
Diluted EPS	82.53	60.27	68.69	111.52
Basic EPS	82.53	60.27	68.69	111.52
Diluted NI Availto Com Stockholders	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Net Income Common Stockholders	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00
Net Income	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Minority Interests	0.00	0.00	0.00	0.00
Net Income Including Noncontrolling Interests	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Net Income Continuous Operations	2.19K Cr	1.60K Cr	1.82K Cr	2.96K Cr
Tax Provision	725.00 Cr	563.00 Cr	545.00 Cr	723.05 Cr
Pretax Income	2.92K Cr	2.16K Cr	2.37K Cr	3.68K Cr
Other Non Operating Income Expenses	4.00 Cr	3.00 Cr	5.00 Cr	4.24 Cr
Special Income Charges	-4.00 Cr	-4.00 Cr	-1.00 Cr	-2.05 Cr
Other Special Charges	4.00 Cr	4.00 Cr	1.00 Cr	2.05 Cr
Net Non Operating Interest Income Expense	292.00 Cr	297.00 Cr	203.00 Cr	66.96 Cr
Total Other Finance Cost	1.00 Cr	1.00 Cr	2.00 Cr	1.63 Cr
Interest Expense Non Operating	2.00 Cr	3.00 Cr	0.00	0.37 Cr
Interest Income Non Operating	295.00 Cr	301.00 Cr	205.00 Cr	68.96 Cr
Operating Income	2.57K Cr	1.83K Cr	2.03K Cr	3.57K Cr
Operating Expense	2.88K Cr	2.69K Cr	2.46K Cr	2.13K Cr
Other Operating Expenses	951.00 Cr	1.01K Cr	960.00 Cr	767.90 Cr
Depreciation And Amortization In Income Statement	402.00 Cr	378.00 Cr	343.00 Cr	311.51 Cr
Amortization	3.00 Cr	3.00 Cr	4.00 Cr	3.18 Cr
Depreciation Income Statement	399.00 Cr	375.00 Cr	339.00 Cr	308.33 Cr
Research And Development	27.00 Cr	35.00 Cr	30.00 Cr	20.29 Cr
Selling General And Administration	279.00 Cr	215.00 Cr	240.00 Cr	235.47 Cr
Selling And Marketing Expense	136.00 Cr	90.00 Cr	114.00 Cr	127.01 Cr
General And Administrative Expense	143.00 Cr	125.00 Cr	126.00 Cr	108.46 Cr
Rent And Landing Fees	15.00 Cr	12.00 Cr	12.00 Cr	10.77 Cr
Gross Profit	5.46K Cr	4.53K Cr	4.49K Cr	5.71K Cr
Cost Of Revenue	3.87K Cr	3.27K Cr	3.18K Cr	3.09K Cr
Total Revenue	9.32K Cr	7.80K Cr	7.67K Cr	8.80K Cr
Operating Revenue	9.32K Cr	7.80K Cr	7.67K Cr	8.80K Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Divis Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.